NCT05359432 - Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes Mellitus | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

August 10, 2021

Study Completion Date

August 18, 2021

Conditions

Type 2 Diabetes

Interventions

DRUG

Empagliflozin

Receiving allocated drug dosage as per clinical needs

DRUG

Vildagliptin

Receiving allocated drug dosage as per clinical needs

Trial Locations (1)

75330

Department of Diabetes and Endocrinology at Sindh Government Hospital New Karachi & Dr. Riasat Medical Center Allah Wala Town, Karachi, Pakistan, Karachi